THBS1 and cancer: The development of the Proclarix 5‐parameter biomarker model (herein referred to as biomarker model) incorporating THBS1, CTSD, tPSA, %fPSA and age was performed on all 955 samples to calculate specificity, NPV and PPV at a fixed sensitivity of 90% to identify significant cancer.